|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:UBE4B-ASCC3 (FusionGDB2 ID:96320) |
Fusion Gene Summary for UBE4B-ASCC3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: UBE4B-ASCC3 | Fusion gene ID: 96320 | Hgene | Tgene | Gene symbol | UBE4B | ASCC3 | Gene ID | 10277 | 10973 |
Gene name | ubiquitination factor E4B | activating signal cointegrator 1 complex subunit 3 | |
Synonyms | E4|HDNB1|UBOX3|UFD2|UFD2A | ASC1p200|HELIC1|RNAH | |
Cytomap | 1p36.22 | 6q16.3 | |
Type of gene | protein-coding | protein-coding | |
Description | ubiquitin conjugation factor E4 BRING-type E3 ubiquitin transferase E4 BUFD2A-III/UBE4B-III splice isoformhomologous to yeast UFD2homozygously deleted in neuroblastoma-1ubiquitin-fusion degradation protein 2ubiquitination factor E4B (UFD2 homolog, y | activating signal cointegrator 1 complex subunit 3ASC-1 complex subunit P200RNA helicase familyhelicase, ATP binding 1trip4 complex subunit p200 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q8N3C0 | |
Ensembl transtripts involved in fusion gene | ENST00000253251, ENST00000343090, ENST00000377153, ENST00000377157, ENST00000475795, | ENST00000369143, ENST00000522650, ENST00000369162, | |
Fusion gene scores | * DoF score | 18 X 13 X 10=2340 | 14 X 10 X 11=1540 |
# samples | 23 | 18 | |
** MAII score | log2(23/2340*10)=-3.34680276352639 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/1540*10)=-3.09686153925259 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: UBE4B [Title/Abstract] AND ASCC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | UBE4B(10093752)-ASCC3(101127628), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | UBE4B | GO:0008626 | granzyme-mediated apoptotic signaling pathway | 11802788 |
Hgene | UBE4B | GO:0009411 | response to UV | 11802788 |
Hgene | UBE4B | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 23509263 |
Tgene | ASCC3 | GO:0006307 | DNA dealkylation involved in DNA repair | 22055184 |
Tgene | ASCC3 | GO:0032508 | DNA duplex unwinding | 22055184 |
Fusion gene breakpoints across UBE4B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ASCC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-BQ-7046-11A | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
Top |
Fusion Gene ORF analysis for UBE4B-ASCC3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000253251 | ENST00000369143 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5CDS-intron | ENST00000253251 | ENST00000522650 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5CDS-intron | ENST00000343090 | ENST00000369143 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5CDS-intron | ENST00000343090 | ENST00000522650 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5CDS-intron | ENST00000377153 | ENST00000369143 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5CDS-intron | ENST00000377153 | ENST00000522650 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5UTR-3CDS | ENST00000377157 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5UTR-intron | ENST00000377157 | ENST00000369143 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
5UTR-intron | ENST00000377157 | ENST00000522650 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
In-frame | ENST00000253251 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
In-frame | ENST00000343090 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
In-frame | ENST00000377153 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
intron-3CDS | ENST00000475795 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
intron-intron | ENST00000475795 | ENST00000369143 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
intron-intron | ENST00000475795 | ENST00000522650 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000253251 | UBE4B | chr1 | 10093752 | + | ENST00000369162 | ASCC3 | chr6 | 101127628 | - | 6513 | 863 | 839 | 5320 | 1493 |
ENST00000343090 | UBE4B | chr1 | 10093752 | + | ENST00000369162 | ASCC3 | chr6 | 101127628 | - | 5749 | 99 | 75 | 4556 | 1493 |
ENST00000377153 | UBE4B | chr1 | 10093752 | + | ENST00000369162 | ASCC3 | chr6 | 101127628 | - | 6071 | 421 | 397 | 4878 | 1493 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000253251 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - | 0.000827962 | 0.9991721 |
ENST00000343090 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - | 0.00030128 | 0.99969876 |
ENST00000377153 | ENST00000369162 | UBE4B | chr1 | 10093752 | + | ASCC3 | chr6 | 101127628 | - | 0.000505788 | 0.9994942 |
Top |
Fusion Genomic Features for UBE4B-ASCC3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for UBE4B-ASCC3 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:10093752/chr6:101127628) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | ASCC3 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: 3'-5' DNA helicase involved in repair of alkylated DNA. Promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3, enabling ALKBH3 to process alkylated N3-methylcytosine (3mC) within double-stranded regions (PubMed:22055184). Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation (PubMed:12077347). {ECO:0000269|PubMed:12077347, ECO:0000269|PubMed:22055184}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 18_79 | 0 | 112.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 328_356 | 0 | 112.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 18_79 | 0 | 732.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 328_356 | 0 | 732.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 1336_1511 | 0 | 112.0 | Domain | Helicase ATP-binding 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 1544_1739 | 0 | 112.0 | Domain | Helicase C-terminal 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 1812_2176 | 0 | 112.0 | Domain | Note=SEC63 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 486_669 | 0 | 112.0 | Domain | Helicase ATP-binding 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 728_914 | 0 | 112.0 | Domain | Helicase C-terminal 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 978_1287 | 0 | 112.0 | Domain | Note=SEC63 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 1336_1511 | 717 | 2203.0 | Domain | Helicase ATP-binding 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 1544_1739 | 717 | 2203.0 | Domain | Helicase C-terminal 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 1812_2176 | 717 | 2203.0 | Domain | Note=SEC63 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 728_914 | 717 | 2203.0 | Domain | Helicase C-terminal 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 978_1287 | 717 | 2203.0 | Domain | Note=SEC63 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 1336_1511 | 0 | 732.0 | Domain | Helicase ATP-binding 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 1544_1739 | 0 | 732.0 | Domain | Helicase C-terminal 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 1812_2176 | 0 | 732.0 | Domain | Note=SEC63 2 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 486_669 | 0 | 732.0 | Domain | Helicase ATP-binding 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 728_914 | 0 | 732.0 | Domain | Helicase C-terminal 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 978_1287 | 0 | 732.0 | Domain | Note=SEC63 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 1453_1456 | 0 | 112.0 | Motif | Note=DEIH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 611_614 | 0 | 112.0 | Motif | Note=DEVH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 1453_1456 | 717 | 2203.0 | Motif | Note=DEIH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 1453_1456 | 0 | 732.0 | Motif | Note=DEIH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 611_614 | 0 | 732.0 | Motif | Note=DEVH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 1349_1356 | 0 | 112.0 | Nucleotide binding | ATP | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369143 | 0 | 4 | 499_506 | 0 | 112.0 | Nucleotide binding | ATP | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 1349_1356 | 717 | 2203.0 | Nucleotide binding | ATP | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 1349_1356 | 0 | 732.0 | Nucleotide binding | ATP | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000522650 | 0 | 13 | 499_506 | 0 | 732.0 | Nucleotide binding | ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | UBE4B | chr1:10093752 | chr6:101127628 | ENST00000253251 | + | 1 | 27 | 1227_1300 | 8 | 1174.0 | Domain | Note=U-box |
Hgene | UBE4B | chr1:10093752 | chr6:101127628 | ENST00000343090 | + | 1 | 28 | 1227_1300 | 8 | 1303.0 | Domain | Note=U-box |
Hgene | UBE4B | chr1:10093752 | chr6:101127628 | ENST00000377157 | + | 1 | 27 | 1227_1300 | 0 | 1062.0 | Domain | Note=U-box |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 18_79 | 717 | 2203.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 328_356 | 717 | 2203.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 486_669 | 717 | 2203.0 | Domain | Helicase ATP-binding 1 | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 611_614 | 717 | 2203.0 | Motif | Note=DEVH box | |
Tgene | ASCC3 | chr1:10093752 | chr6:101127628 | ENST00000369162 | 12 | 42 | 499_506 | 717 | 2203.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for UBE4B-ASCC3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>96320_96320_1_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000253251_ASCC3_chr6_101127628_ENST00000369162_length(transcript)=6513nt_BP=863nt GACGGGGTGGGACGGAGGCGGGGAGAGGACGCAGGCGAGAGGAACTCGGCGGCGCGGCGCCCGCGGCCTATTGGCTGCCACGTCCCGGCG CCAGAAGCCCCGCCTCCCTGACGGGGGTCACGTGATCCCTTTCAAAGATGGCCGCCCTGTTGTTTTGATGAATAATACTTGGTGGGGCGA GGGGGAAAGAGTAGGGGTGGAGGGGTAGGAGGATTTACTCTTCCAGCGAGAGCTACGCGCATCCCATCCTCCCCCTCCCCCCTACCCGGG CTCCGGCGTGGAGGCGGGGCGTGGCCGGCCTGCTTTGGGAGGGGAGGGGCTTCCCTTACAGTGCTGGGCTCTGCCAGGACGGCTGTGGGG TCGCCTTACCTCGGGGTATCCACTCTGCAGTCGACCAGTTCCCGCCAGGAGCAAAGGGTAGGAAGGAGAGCAGGATCTGCTGTAGGAACG CAGCTACCGCGCCACTATCACGAAGAAACAGCAGGCTCGGGGCACGAGACGAACTGGAGACCGCGCTGCCTAGCTGGGTAACCTGGGAAG CAGAGGGTAATAAGTGGCGCCTTAAGACAACCCTGTAGCAGCAGCAGTGGCGGCCAAAGGAGGCTGCTCAGGGAACAAGCGGCTGTAGTA GTCTGTGGGGCGACTGGAGTGACCGAAGCCAAGGCAGTTTAGTGCCTCTCGTGTTCTTATTTTTTAACCTCTGACTATGCAATTCTGAAA CCTCCCCCATTCGGGGGACCAGACAGCCTGATAGACACCTTCCACTCTCCTTCCTCCCGCCGTGGTCTCGAGAACAGAAGGATCTCTCCT TAACGCCTTTCACCATTAAGAGGAAAGCGATGGAGGAGCTGAGCGCTGATGAGGTGATGGTGTTTGTACATGCTCGAAATGCCACTGTAA GAACAGCTATGTCTCTAATAGAAAGAGCAAAAAATTGTGGCCATATTCCCTTCTTTTTTCCTACCCAAGGACATGACTATGTACTTGCAG AAAAACAGGTACAAAGGTCGAGAAATAAGCAAGTACGAGAATTATTCCCAGATGGTTTTAGTATTCATCATGCAGGAATGCTTCGGCAGG ACAGAAATTTAGTTGAAAACTTGTTTTCTAATGGGCATATCAAAGTCCTAGTGTGTACAGCTACGTTAGCCTGGGGTGTCAATCTTCCCG CCCATGCTGTTATTATTAAGGGAACACAAATATATGCTGCAAAAAGAGGCTCCTTTGTTGACCTTGGAATTTTAGATGTCATGCAGATAT TTGGTCGAGCTGGACGACCACAATTTGACAAATTTGGGGAAGGAATAATTATAACAACGCATGATAAACTCAGCCATTACCTCACTTTGC TCACTCAACGAAACCCAATTGAGAGTCAGTTTCTGGAAAGCCTTGCAGATAACCTAAATGCAGAGATTGCTCTGGGAACAGTTACTAATG TGGAAGAAGCAGTGAAGTGGATAAGTTACACTTATCTTTATGTACGGATGAGAGCAAATCCATTAGCATATGGCATCAGTCACAAGGCTT ATCAGATTGACCCAACATTAAGAAAGCATCGAGAACAGTTGGTCATTGAAGTTGGACGAAAACTAGACAAAGCTCAGATGATTCGTTTTG AGGAGCGAACTGGATATTTTTCCTCAACTGATTTGGGTAGAACTGCCAGCCATTACTATATTAAATACAACACCATTGAGACCTTTAATG AACTCTTTGATGCTCACAAAACAGAAGGTGATATCTTTGCCATAGTCTCCAAAGCTGAAGAATTTGATCAAATTAAGGTCAGAGAAGAGG AAATAGAGGAGTTAGATACCTTATTAAGCAATTTTTGTGAACTCTCCACTCCTGGAGGTGTAGAGAATAGTTATGGGAAAATAAACATCT TACTTCAAACTTATATCAGCCGAGGAGAAATGGACAGTTTCTCCCTTATATCAGATTCTGCATATGTTGCACAGAATGCAGCTAGAATTG TCCGTGCTCTTTTTGAAATTGCTCTGAGGAAACGTTGGCCTACCATGACCTACAGGCTCCTGAATCTTAGTAAAGTCATTGACAAGAGGC TTTGGGGTTGGGCTAGCCCTTTGAGACAATTTTCAATCCTACCACCACACATCCTAACAAGATTAGAAGAAAAAAAGCTTACTGTGGATA AGCTGAAAGACATGAGGAAAGATGAAATAGGTCACATTTTACATCATGTGAATATTGGACTGAAGGTCAAACAATGTGTTCATCAGATTC CTTCTGTTATGATGGAAGCATCCATTCAGCCTATCACAAGGACTGTCCTCCGAGTGACACTCAGCATCTATGCTGATTTCACTTGGAATG ATCAGGTACATGGGACAGTAGGAGAACCTTGGTGGATTTGGGTAGAAGATCCTACAAATGATCATATTTATCATTCAGAGTATTTTCTAG CTCTAAAAAAACAAGTCATTAGTAAAGAAGCCCAACTACTGGTATTTACAATCCCTATTTTTGAGCCTTTGCCTTCCCAATACTACATCC GAGCAGTGTCTGATAGATGGTTGGGTGCTGAGGCAGTATGTATTATCAACTTTCAACATCTAATTCTACCAGAGAGACATCCTCCTCATA CAGAATTACTGGATCTTCAGCCTTTACCAATCACAGCTTTGGGATGTAAAGCATATGAAGCCCTGTACAACTTCAGCCACTTTAACCCTG TACAGACACAAATATTTCATACATTGTATCACACGGATTGTAATGTCCTACTTGGAGCACCTACTGGATCGGGAAAGACTGTTGCAGCTG AATTAGCCATTTTCAGAGTCTTCAACAAATACCCTACTTCAAAGGCGGTATATATTGCACCCCTAAAAGCCCTAGTACGTGAAAGAATGG ATGATTGGAAAGTTAGAATAGAAGAAAAACTTGGTAAAAAAGTTATTGAACTAACAGGGGATGTGACTCCTGATATGAAATCCATTGCCA AGGCTGACCTTATCGTCACTACGCCAGAGAAGTGGGATGGAGTCAGCAGAAGCTGGCAAAATAGGAACTATGTTCAGCAAGTCACTATTC TCATCATAGATGAGATCCATCTGCTTGGGGAGGAAAGAGGCCCTGTTCTAGAGGTCATTGTATCTCGAACAAATTTTATCTCATCACACA CAGAAAAGCCTGTTAGAATAGTTGGACTATCTACTGCATTAGCTAATGCCAGAGACCTTGCTGATTGGCTCAATATTAAGCAGATGGGCT TGTTTAACTTCCGACCATCAGTACGCCCAGTTCCACTGGAAGTTCACATTCAAGGCTTTCCAGGTCAACATTACTGTCCTCGTATGGCTA GTATGAACAAGCCTGCATTTCAGGCAATTAGAAGCCATTCTCCAGCCAAACCTGTTTTGATATTTGTCTCATCAAGACGTCAAACTCGTC TTACTGCTTTGGAATTGATCGCCTTCCTGGCTACTGAAGAAGATCCAAAGCAGTGGTTAAACATGGATGAAAGAGAGATGGAGAACATCA TTGCAACAGTAAGAGATTCCAACCTCAAGCTGACCCTTGCTTTCGGGATAGGAATGCATCATGCTGGACTACATGAGAGGGACCGAAAAA CAGTAGAGGAACTATTTGTAAACTGTAAAGTTCAGGTTCTTATTGCTACAAGCACATTAGCCTGGGGTGTAAACTTTCCAGCTCATTTAG TAATTATTAAGGGAACAGAATACTATGATGGAAAAACAAGACGTTATGTGGATTTTCCCATTACAGATGTCCTCCAGATGATGGGGCGTG CTGGGAGGCCGCAGTTCGATGACCAAGGCAAAGCTGTAATTCTAGTTCATGACATAAAGAAAGACTTTTATAAAAAATTTCTTTATGAAC CTTTCCCAGTAGAATCAAGTTTATTAGGAGTGCTCTCTGACCACTTAAATGCAGAGATTGCTGGTGGTACAATTACATCTAAGCAAGATG CATTGGATTATATCACCTGGACTTACTTTTTCCGACGTCTTATCATGAATCCCAGCTATTACAATTTGGGTGATGTGAGCCATGATTCTG TGAACAAGTTTCTGTCCCATCTGATTGAGAAGTCCCTGATTGAATTGGAACTTTCCTACTGTATTGAAATTGGAGAGGATAATCGCAGCA TTGAACCTCTAACTTATGGCCGAATTGCCTCCTATTACTATTTGAAGCATCAAACAGTTAAAATGTTCAAGGACCGCTTGAAGCCTGAAT GCAGTACTGAAGAACTGCTTTCAATTCTAAGTGATGCAGAAGAATATACAGATTTGCCAGTGAGACACAATGAAGATCATATGAATAGTG AACTGGCAAAATGTCTTCCCATTGAATCAAATCCTCATTCATTTGACAGCCCTCACACCAAAGCACATCTCCTGCTACAGGCACATCTCA GCCGAGCCATGCTACCCTGCCCAGATTATGACACTGATACCAAAACAGTCTTGGACCAAGCTCTCAGAGTATGTCAGGCAATGCTGGACG TGGCTGCAAACCAGGGCTGGCTGGTGACTGTCCTGAATATCACCAACCTGATTCAGATGGTGATCCAGGGTCGGTGGTTAAAGGACTCTT CTCTTCTTACACTACCAAACATAGAAAACCATCATCTTCACCTTTTCAAGAAATGGAAGCCGATTATGAAGGGCCCACATGCTAGGGGTC GGACCTCCATCGAGTCCCTTCCTGAACTGATCCATGCCTGTGGAGGGAAAGACCATGTATTTAGCTCCATGGTAGAAAGTGAGCTACATG CTGCAAAAACGAAACAGGCATGGAATTTCTTATCTCACTTGCCAGTGATAAATGTTGGCATAAGTGTTAAAGGCTCGTGGGATGACTTAG TTGAAGGACATAATGAACTCTCTGTCTCAACTCTGACTGCAGACAAACGAGATGACAACAAATGGATCAAATTGCATGCTGACCAAGAGT ATGTGCTTCAAGTGAGCTTGCAGAGAGTCCACTTTGGGTTCCACAAGGGAAAGCCAGAGAGCTGTGCAGTTACTCCTCGATTTCCCAAAT CAAAAGACGAAGGATGGTTTTTGATATTAGGAGAAGTGGATAAGAGAGAACTTATTGCTTTGAAAAGAGTAGGATATATTCGAAATCATC ATGTTGCTTCCCTTTCTTTTTATACCCCTGAAATACCTGGAAGGTATATCTACACATTATATTTCATGAGTGACTGCTACCTTGGCCTGG ACCAGCAGTATGACATCTATCTCAACGTTACACAAGCGAGTCTTTCTGCACAGGTCAACACCAAGGTCTCTGATTCCCTGACTGACCTGG CATTAAAGTAACTTGACCTGAACAATCCATTTGAAAGGAGTGGCTAAGAATTCTCTCTGTTCAGTCATCTAGACAAATCGAATTACTTGA TGTTTGCCTTGAAAGAATCAACTTCTAACCTCAACCATCCAGGAAATTGACAGTGGCTGCAGTATTGACTCCAGTGACATAAAGTTAACC ACAGTGGCCTTTTAACAAATGTTGCCTTTTATAATGTTATCTTTATGAGTTTCTTGATATGTAAGATGAAAAAGCATTTAGAATAATCTT TTAATTTGTGTATATTTGGGATGATATTTAGGAGCTATCAATCAAATTTTACATCTCACAATGTACTGTTTACATGGATATTGGCTGCTT TTTTTAAGGAAAACCACATTGAGATGTGACAAGTGTTAGGACTTGTCACAGATTTCTAACTCTGCCGCATAAACTATAAATCTGTAAGGT GGTACACAGCGTGTCTTGTTAGCAAAATTTATACTTTGATATGATCACATGTAGAAGTAGCTTCAAGAATTTCTTGTAGTCATAAATGTT TAATAATATATGATGTAAAATTATATTATGGAGCCTAATGATGATAACAAAGAAAACAATATACTGATCTTAGAAAATGTAGACATGGTT AACTGGGAAATAAAATATAGAGTGGCACTTCAAGACAAGCTGACTCAATGTTTTCTTCTGCTTCCTTTAAATAATATCCCCTTACTCATC TGTTCTTCTTTTCTTTCCCTTCTACTTCAAGGCTTTATTTCTATTATCTTTCTGACATATTTATTTACAGAAGTAGAGAAGTATAATCTA ATTCATGTTGTAGCACTTACAGATCATATAGTACAATTATTTGTCTTTATGCTCTCCAGGAAAAATCTGAGACAGAAAATTTTTCACCCC TATGGATAGGTTTTCACCTGTAATAAAGAAAATTTCTCTATGTCCAAACAAATTCCTTCTTGAAAAATACTTTTTCAAACTAAAAACTTG TTAAAATTCAATGTTCATATAATATGCATTCTAGTGGAATGAAATTCTACCTTTGTGAAATAATTTCAGTTTTCTTAGCCCTAAAATGAA TTATTTTAAAACATTTTCCAATGTCATTGTTACAAATACTAGAATTTAAGTGTTTCTGAAATTGGAATGTATTGCTTGTATATATCCTTT >96320_96320_1_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000253251_ASCC3_chr6_101127628_ENST00000369162_length(amino acids)=1493AA_BP=735 MEELSADEVMVFVHARNATVRTAMSLIERAKNCGHIPFFFPTQGHDYVLAEKQVQRSRNKQVRELFPDGFSIHHAGMLRQDRNLVENLFS NGHIKVLVCTATLAWGVNLPAHAVIIKGTQIYAAKRGSFVDLGILDVMQIFGRAGRPQFDKFGEGIIITTHDKLSHYLTLLTQRNPIESQ FLESLADNLNAEIALGTVTNVEEAVKWISYTYLYVRMRANPLAYGISHKAYQIDPTLRKHREQLVIEVGRKLDKAQMIRFEERTGYFSST DLGRTASHYYIKYNTIETFNELFDAHKTEGDIFAIVSKAEEFDQIKVREEEIEELDTLLSNFCELSTPGGVENSYGKINILLQTYISRGE MDSFSLISDSAYVAQNAARIVRALFEIALRKRWPTMTYRLLNLSKVIDKRLWGWASPLRQFSILPPHILTRLEEKKLTVDKLKDMRKDEI GHILHHVNIGLKVKQCVHQIPSVMMEASIQPITRTVLRVTLSIYADFTWNDQVHGTVGEPWWIWVEDPTNDHIYHSEYFLALKKQVISKE AQLLVFTIPIFEPLPSQYYIRAVSDRWLGAEAVCIINFQHLILPERHPPHTELLDLQPLPITALGCKAYEALYNFSHFNPVQTQIFHTLY HTDCNVLLGAPTGSGKTVAAELAIFRVFNKYPTSKAVYIAPLKALVRERMDDWKVRIEEKLGKKVIELTGDVTPDMKSIAKADLIVTTPE KWDGVSRSWQNRNYVQQVTILIIDEIHLLGEERGPVLEVIVSRTNFISSHTEKPVRIVGLSTALANARDLADWLNIKQMGLFNFRPSVRP VPLEVHIQGFPGQHYCPRMASMNKPAFQAIRSHSPAKPVLIFVSSRRQTRLTALELIAFLATEEDPKQWLNMDEREMENIIATVRDSNLK LTLAFGIGMHHAGLHERDRKTVEELFVNCKVQVLIATSTLAWGVNFPAHLVIIKGTEYYDGKTRRYVDFPITDVLQMMGRAGRPQFDDQG KAVILVHDIKKDFYKKFLYEPFPVESSLLGVLSDHLNAEIAGGTITSKQDALDYITWTYFFRRLIMNPSYYNLGDVSHDSVNKFLSHLIE KSLIELELSYCIEIGEDNRSIEPLTYGRIASYYYLKHQTVKMFKDRLKPECSTEELLSILSDAEEYTDLPVRHNEDHMNSELAKCLPIES NPHSFDSPHTKAHLLLQAHLSRAMLPCPDYDTDTKTVLDQALRVCQAMLDVAANQGWLVTVLNITNLIQMVIQGRWLKDSSLLTLPNIEN HHLHLFKKWKPIMKGPHARGRTSIESLPELIHACGGKDHVFSSMVESELHAAKTKQAWNFLSHLPVINVGISVKGSWDDLVEGHNELSVS TLTADKRDDNKWIKLHADQEYVLQVSLQRVHFGFHKGKPESCAVTPRFPKSKDEGWFLILGEVDKRELIALKRVGYIRNHHVASLSFYTP -------------------------------------------------------------- >96320_96320_2_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000343090_ASCC3_chr6_101127628_ENST00000369162_length(transcript)=5749nt_BP=99nt CTCTCCTTCCTCCCGCCGTGGTCTCGAGAACAGAAGGATCTCTCCTTAACGCCTTTCACCATTAAGAGGAAAGCGATGGAGGAGCTGAGC GCTGATGAGGTGATGGTGTTTGTACATGCTCGAAATGCCACTGTAAGAACAGCTATGTCTCTAATAGAAAGAGCAAAAAATTGTGGCCAT ATTCCCTTCTTTTTTCCTACCCAAGGACATGACTATGTACTTGCAGAAAAACAGGTACAAAGGTCGAGAAATAAGCAAGTACGAGAATTA TTCCCAGATGGTTTTAGTATTCATCATGCAGGAATGCTTCGGCAGGACAGAAATTTAGTTGAAAACTTGTTTTCTAATGGGCATATCAAA GTCCTAGTGTGTACAGCTACGTTAGCCTGGGGTGTCAATCTTCCCGCCCATGCTGTTATTATTAAGGGAACACAAATATATGCTGCAAAA AGAGGCTCCTTTGTTGACCTTGGAATTTTAGATGTCATGCAGATATTTGGTCGAGCTGGACGACCACAATTTGACAAATTTGGGGAAGGA ATAATTATAACAACGCATGATAAACTCAGCCATTACCTCACTTTGCTCACTCAACGAAACCCAATTGAGAGTCAGTTTCTGGAAAGCCTT GCAGATAACCTAAATGCAGAGATTGCTCTGGGAACAGTTACTAATGTGGAAGAAGCAGTGAAGTGGATAAGTTACACTTATCTTTATGTA CGGATGAGAGCAAATCCATTAGCATATGGCATCAGTCACAAGGCTTATCAGATTGACCCAACATTAAGAAAGCATCGAGAACAGTTGGTC ATTGAAGTTGGACGAAAACTAGACAAAGCTCAGATGATTCGTTTTGAGGAGCGAACTGGATATTTTTCCTCAACTGATTTGGGTAGAACT GCCAGCCATTACTATATTAAATACAACACCATTGAGACCTTTAATGAACTCTTTGATGCTCACAAAACAGAAGGTGATATCTTTGCCATA GTCTCCAAAGCTGAAGAATTTGATCAAATTAAGGTCAGAGAAGAGGAAATAGAGGAGTTAGATACCTTATTAAGCAATTTTTGTGAACTC TCCACTCCTGGAGGTGTAGAGAATAGTTATGGGAAAATAAACATCTTACTTCAAACTTATATCAGCCGAGGAGAAATGGACAGTTTCTCC CTTATATCAGATTCTGCATATGTTGCACAGAATGCAGCTAGAATTGTCCGTGCTCTTTTTGAAATTGCTCTGAGGAAACGTTGGCCTACC ATGACCTACAGGCTCCTGAATCTTAGTAAAGTCATTGACAAGAGGCTTTGGGGTTGGGCTAGCCCTTTGAGACAATTTTCAATCCTACCA CCACACATCCTAACAAGATTAGAAGAAAAAAAGCTTACTGTGGATAAGCTGAAAGACATGAGGAAAGATGAAATAGGTCACATTTTACAT CATGTGAATATTGGACTGAAGGTCAAACAATGTGTTCATCAGATTCCTTCTGTTATGATGGAAGCATCCATTCAGCCTATCACAAGGACT GTCCTCCGAGTGACACTCAGCATCTATGCTGATTTCACTTGGAATGATCAGGTACATGGGACAGTAGGAGAACCTTGGTGGATTTGGGTA GAAGATCCTACAAATGATCATATTTATCATTCAGAGTATTTTCTAGCTCTAAAAAAACAAGTCATTAGTAAAGAAGCCCAACTACTGGTA TTTACAATCCCTATTTTTGAGCCTTTGCCTTCCCAATACTACATCCGAGCAGTGTCTGATAGATGGTTGGGTGCTGAGGCAGTATGTATT ATCAACTTTCAACATCTAATTCTACCAGAGAGACATCCTCCTCATACAGAATTACTGGATCTTCAGCCTTTACCAATCACAGCTTTGGGA TGTAAAGCATATGAAGCCCTGTACAACTTCAGCCACTTTAACCCTGTACAGACACAAATATTTCATACATTGTATCACACGGATTGTAAT GTCCTACTTGGAGCACCTACTGGATCGGGAAAGACTGTTGCAGCTGAATTAGCCATTTTCAGAGTCTTCAACAAATACCCTACTTCAAAG GCGGTATATATTGCACCCCTAAAAGCCCTAGTACGTGAAAGAATGGATGATTGGAAAGTTAGAATAGAAGAAAAACTTGGTAAAAAAGTT ATTGAACTAACAGGGGATGTGACTCCTGATATGAAATCCATTGCCAAGGCTGACCTTATCGTCACTACGCCAGAGAAGTGGGATGGAGTC AGCAGAAGCTGGCAAAATAGGAACTATGTTCAGCAAGTCACTATTCTCATCATAGATGAGATCCATCTGCTTGGGGAGGAAAGAGGCCCT GTTCTAGAGGTCATTGTATCTCGAACAAATTTTATCTCATCACACACAGAAAAGCCTGTTAGAATAGTTGGACTATCTACTGCATTAGCT AATGCCAGAGACCTTGCTGATTGGCTCAATATTAAGCAGATGGGCTTGTTTAACTTCCGACCATCAGTACGCCCAGTTCCACTGGAAGTT CACATTCAAGGCTTTCCAGGTCAACATTACTGTCCTCGTATGGCTAGTATGAACAAGCCTGCATTTCAGGCAATTAGAAGCCATTCTCCA GCCAAACCTGTTTTGATATTTGTCTCATCAAGACGTCAAACTCGTCTTACTGCTTTGGAATTGATCGCCTTCCTGGCTACTGAAGAAGAT CCAAAGCAGTGGTTAAACATGGATGAAAGAGAGATGGAGAACATCATTGCAACAGTAAGAGATTCCAACCTCAAGCTGACCCTTGCTTTC GGGATAGGAATGCATCATGCTGGACTACATGAGAGGGACCGAAAAACAGTAGAGGAACTATTTGTAAACTGTAAAGTTCAGGTTCTTATT GCTACAAGCACATTAGCCTGGGGTGTAAACTTTCCAGCTCATTTAGTAATTATTAAGGGAACAGAATACTATGATGGAAAAACAAGACGT TATGTGGATTTTCCCATTACAGATGTCCTCCAGATGATGGGGCGTGCTGGGAGGCCGCAGTTCGATGACCAAGGCAAAGCTGTAATTCTA GTTCATGACATAAAGAAAGACTTTTATAAAAAATTTCTTTATGAACCTTTCCCAGTAGAATCAAGTTTATTAGGAGTGCTCTCTGACCAC TTAAATGCAGAGATTGCTGGTGGTACAATTACATCTAAGCAAGATGCATTGGATTATATCACCTGGACTTACTTTTTCCGACGTCTTATC ATGAATCCCAGCTATTACAATTTGGGTGATGTGAGCCATGATTCTGTGAACAAGTTTCTGTCCCATCTGATTGAGAAGTCCCTGATTGAA TTGGAACTTTCCTACTGTATTGAAATTGGAGAGGATAATCGCAGCATTGAACCTCTAACTTATGGCCGAATTGCCTCCTATTACTATTTG AAGCATCAAACAGTTAAAATGTTCAAGGACCGCTTGAAGCCTGAATGCAGTACTGAAGAACTGCTTTCAATTCTAAGTGATGCAGAAGAA TATACAGATTTGCCAGTGAGACACAATGAAGATCATATGAATAGTGAACTGGCAAAATGTCTTCCCATTGAATCAAATCCTCATTCATTT GACAGCCCTCACACCAAAGCACATCTCCTGCTACAGGCACATCTCAGCCGAGCCATGCTACCCTGCCCAGATTATGACACTGATACCAAA ACAGTCTTGGACCAAGCTCTCAGAGTATGTCAGGCAATGCTGGACGTGGCTGCAAACCAGGGCTGGCTGGTGACTGTCCTGAATATCACC AACCTGATTCAGATGGTGATCCAGGGTCGGTGGTTAAAGGACTCTTCTCTTCTTACACTACCAAACATAGAAAACCATCATCTTCACCTT TTCAAGAAATGGAAGCCGATTATGAAGGGCCCACATGCTAGGGGTCGGACCTCCATCGAGTCCCTTCCTGAACTGATCCATGCCTGTGGA GGGAAAGACCATGTATTTAGCTCCATGGTAGAAAGTGAGCTACATGCTGCAAAAACGAAACAGGCATGGAATTTCTTATCTCACTTGCCA GTGATAAATGTTGGCATAAGTGTTAAAGGCTCGTGGGATGACTTAGTTGAAGGACATAATGAACTCTCTGTCTCAACTCTGACTGCAGAC AAACGAGATGACAACAAATGGATCAAATTGCATGCTGACCAAGAGTATGTGCTTCAAGTGAGCTTGCAGAGAGTCCACTTTGGGTTCCAC AAGGGAAAGCCAGAGAGCTGTGCAGTTACTCCTCGATTTCCCAAATCAAAAGACGAAGGATGGTTTTTGATATTAGGAGAAGTGGATAAG AGAGAACTTATTGCTTTGAAAAGAGTAGGATATATTCGAAATCATCATGTTGCTTCCCTTTCTTTTTATACCCCTGAAATACCTGGAAGG TATATCTACACATTATATTTCATGAGTGACTGCTACCTTGGCCTGGACCAGCAGTATGACATCTATCTCAACGTTACACAAGCGAGTCTT TCTGCACAGGTCAACACCAAGGTCTCTGATTCCCTGACTGACCTGGCATTAAAGTAACTTGACCTGAACAATCCATTTGAAAGGAGTGGC TAAGAATTCTCTCTGTTCAGTCATCTAGACAAATCGAATTACTTGATGTTTGCCTTGAAAGAATCAACTTCTAACCTCAACCATCCAGGA AATTGACAGTGGCTGCAGTATTGACTCCAGTGACATAAAGTTAACCACAGTGGCCTTTTAACAAATGTTGCCTTTTATAATGTTATCTTT ATGAGTTTCTTGATATGTAAGATGAAAAAGCATTTAGAATAATCTTTTAATTTGTGTATATTTGGGATGATATTTAGGAGCTATCAATCA AATTTTACATCTCACAATGTACTGTTTACATGGATATTGGCTGCTTTTTTTAAGGAAAACCACATTGAGATGTGACAAGTGTTAGGACTT GTCACAGATTTCTAACTCTGCCGCATAAACTATAAATCTGTAAGGTGGTACACAGCGTGTCTTGTTAGCAAAATTTATACTTTGATATGA TCACATGTAGAAGTAGCTTCAAGAATTTCTTGTAGTCATAAATGTTTAATAATATATGATGTAAAATTATATTATGGAGCCTAATGATGA TAACAAAGAAAACAATATACTGATCTTAGAAAATGTAGACATGGTTAACTGGGAAATAAAATATAGAGTGGCACTTCAAGACAAGCTGAC TCAATGTTTTCTTCTGCTTCCTTTAAATAATATCCCCTTACTCATCTGTTCTTCTTTTCTTTCCCTTCTACTTCAAGGCTTTATTTCTAT TATCTTTCTGACATATTTATTTACAGAAGTAGAGAAGTATAATCTAATTCATGTTGTAGCACTTACAGATCATATAGTACAATTATTTGT CTTTATGCTCTCCAGGAAAAATCTGAGACAGAAAATTTTTCACCCCTATGGATAGGTTTTCACCTGTAATAAAGAAAATTTCTCTATGTC CAAACAAATTCCTTCTTGAAAAATACTTTTTCAAACTAAAAACTTGTTAAAATTCAATGTTCATATAATATGCATTCTAGTGGAATGAAA TTCTACCTTTGTGAAATAATTTCAGTTTTCTTAGCCCTAAAATGAATTATTTTAAAACATTTTCCAATGTCATTGTTACAAATACTAGAA >96320_96320_2_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000343090_ASCC3_chr6_101127628_ENST00000369162_length(amino acids)=1493AA_BP=735 MEELSADEVMVFVHARNATVRTAMSLIERAKNCGHIPFFFPTQGHDYVLAEKQVQRSRNKQVRELFPDGFSIHHAGMLRQDRNLVENLFS NGHIKVLVCTATLAWGVNLPAHAVIIKGTQIYAAKRGSFVDLGILDVMQIFGRAGRPQFDKFGEGIIITTHDKLSHYLTLLTQRNPIESQ FLESLADNLNAEIALGTVTNVEEAVKWISYTYLYVRMRANPLAYGISHKAYQIDPTLRKHREQLVIEVGRKLDKAQMIRFEERTGYFSST DLGRTASHYYIKYNTIETFNELFDAHKTEGDIFAIVSKAEEFDQIKVREEEIEELDTLLSNFCELSTPGGVENSYGKINILLQTYISRGE MDSFSLISDSAYVAQNAARIVRALFEIALRKRWPTMTYRLLNLSKVIDKRLWGWASPLRQFSILPPHILTRLEEKKLTVDKLKDMRKDEI GHILHHVNIGLKVKQCVHQIPSVMMEASIQPITRTVLRVTLSIYADFTWNDQVHGTVGEPWWIWVEDPTNDHIYHSEYFLALKKQVISKE AQLLVFTIPIFEPLPSQYYIRAVSDRWLGAEAVCIINFQHLILPERHPPHTELLDLQPLPITALGCKAYEALYNFSHFNPVQTQIFHTLY HTDCNVLLGAPTGSGKTVAAELAIFRVFNKYPTSKAVYIAPLKALVRERMDDWKVRIEEKLGKKVIELTGDVTPDMKSIAKADLIVTTPE KWDGVSRSWQNRNYVQQVTILIIDEIHLLGEERGPVLEVIVSRTNFISSHTEKPVRIVGLSTALANARDLADWLNIKQMGLFNFRPSVRP VPLEVHIQGFPGQHYCPRMASMNKPAFQAIRSHSPAKPVLIFVSSRRQTRLTALELIAFLATEEDPKQWLNMDEREMENIIATVRDSNLK LTLAFGIGMHHAGLHERDRKTVEELFVNCKVQVLIATSTLAWGVNFPAHLVIIKGTEYYDGKTRRYVDFPITDVLQMMGRAGRPQFDDQG KAVILVHDIKKDFYKKFLYEPFPVESSLLGVLSDHLNAEIAGGTITSKQDALDYITWTYFFRRLIMNPSYYNLGDVSHDSVNKFLSHLIE KSLIELELSYCIEIGEDNRSIEPLTYGRIASYYYLKHQTVKMFKDRLKPECSTEELLSILSDAEEYTDLPVRHNEDHMNSELAKCLPIES NPHSFDSPHTKAHLLLQAHLSRAMLPCPDYDTDTKTVLDQALRVCQAMLDVAANQGWLVTVLNITNLIQMVIQGRWLKDSSLLTLPNIEN HHLHLFKKWKPIMKGPHARGRTSIESLPELIHACGGKDHVFSSMVESELHAAKTKQAWNFLSHLPVINVGISVKGSWDDLVEGHNELSVS TLTADKRDDNKWIKLHADQEYVLQVSLQRVHFGFHKGKPESCAVTPRFPKSKDEGWFLILGEVDKRELIALKRVGYIRNHHVASLSFYTP -------------------------------------------------------------- >96320_96320_3_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000377153_ASCC3_chr6_101127628_ENST00000369162_length(transcript)=6071nt_BP=421nt TAGGAACGCAGCTACCGCGCCACTATCACGAAGAAACAGCAGGCTCGGGGCACGAGACGAACTGGAGACCGCGCTGCCTAGCTGGGTAAC CTGGGAAGCAGAGGGTAATAAGTGGCGCCTTAAGACAACCCTGTAGCAGCAGCAGTGGCGGCCAAAGGAGGCTGCTCAGGGAACAAGCGG CTGTAGTAGTCTGTGGGGCGACTGGAGTGACCGAAGCCAAGGCAGTTTAGTGCCTCTCGTGTTCTTATTTTTTAACCTCTGACTATGCAA TTCTGAAACCTCCCCCATTCGGGGGACCAGACAGCCTGATAGACACCTTCCACTCTCCTTCCTCCCGCCGTGGTCTCGAGAACAGAAGGA TCTCTCCTTAACGCCTTTCACCATTAAGAGGAAAGCGATGGAGGAGCTGAGCGCTGATGAGGTGATGGTGTTTGTACATGCTCGAAATGC CACTGTAAGAACAGCTATGTCTCTAATAGAAAGAGCAAAAAATTGTGGCCATATTCCCTTCTTTTTTCCTACCCAAGGACATGACTATGT ACTTGCAGAAAAACAGGTACAAAGGTCGAGAAATAAGCAAGTACGAGAATTATTCCCAGATGGTTTTAGTATTCATCATGCAGGAATGCT TCGGCAGGACAGAAATTTAGTTGAAAACTTGTTTTCTAATGGGCATATCAAAGTCCTAGTGTGTACAGCTACGTTAGCCTGGGGTGTCAA TCTTCCCGCCCATGCTGTTATTATTAAGGGAACACAAATATATGCTGCAAAAAGAGGCTCCTTTGTTGACCTTGGAATTTTAGATGTCAT GCAGATATTTGGTCGAGCTGGACGACCACAATTTGACAAATTTGGGGAAGGAATAATTATAACAACGCATGATAAACTCAGCCATTACCT CACTTTGCTCACTCAACGAAACCCAATTGAGAGTCAGTTTCTGGAAAGCCTTGCAGATAACCTAAATGCAGAGATTGCTCTGGGAACAGT TACTAATGTGGAAGAAGCAGTGAAGTGGATAAGTTACACTTATCTTTATGTACGGATGAGAGCAAATCCATTAGCATATGGCATCAGTCA CAAGGCTTATCAGATTGACCCAACATTAAGAAAGCATCGAGAACAGTTGGTCATTGAAGTTGGACGAAAACTAGACAAAGCTCAGATGAT TCGTTTTGAGGAGCGAACTGGATATTTTTCCTCAACTGATTTGGGTAGAACTGCCAGCCATTACTATATTAAATACAACACCATTGAGAC CTTTAATGAACTCTTTGATGCTCACAAAACAGAAGGTGATATCTTTGCCATAGTCTCCAAAGCTGAAGAATTTGATCAAATTAAGGTCAG AGAAGAGGAAATAGAGGAGTTAGATACCTTATTAAGCAATTTTTGTGAACTCTCCACTCCTGGAGGTGTAGAGAATAGTTATGGGAAAAT AAACATCTTACTTCAAACTTATATCAGCCGAGGAGAAATGGACAGTTTCTCCCTTATATCAGATTCTGCATATGTTGCACAGAATGCAGC TAGAATTGTCCGTGCTCTTTTTGAAATTGCTCTGAGGAAACGTTGGCCTACCATGACCTACAGGCTCCTGAATCTTAGTAAAGTCATTGA CAAGAGGCTTTGGGGTTGGGCTAGCCCTTTGAGACAATTTTCAATCCTACCACCACACATCCTAACAAGATTAGAAGAAAAAAAGCTTAC TGTGGATAAGCTGAAAGACATGAGGAAAGATGAAATAGGTCACATTTTACATCATGTGAATATTGGACTGAAGGTCAAACAATGTGTTCA TCAGATTCCTTCTGTTATGATGGAAGCATCCATTCAGCCTATCACAAGGACTGTCCTCCGAGTGACACTCAGCATCTATGCTGATTTCAC TTGGAATGATCAGGTACATGGGACAGTAGGAGAACCTTGGTGGATTTGGGTAGAAGATCCTACAAATGATCATATTTATCATTCAGAGTA TTTTCTAGCTCTAAAAAAACAAGTCATTAGTAAAGAAGCCCAACTACTGGTATTTACAATCCCTATTTTTGAGCCTTTGCCTTCCCAATA CTACATCCGAGCAGTGTCTGATAGATGGTTGGGTGCTGAGGCAGTATGTATTATCAACTTTCAACATCTAATTCTACCAGAGAGACATCC TCCTCATACAGAATTACTGGATCTTCAGCCTTTACCAATCACAGCTTTGGGATGTAAAGCATATGAAGCCCTGTACAACTTCAGCCACTT TAACCCTGTACAGACACAAATATTTCATACATTGTATCACACGGATTGTAATGTCCTACTTGGAGCACCTACTGGATCGGGAAAGACTGT TGCAGCTGAATTAGCCATTTTCAGAGTCTTCAACAAATACCCTACTTCAAAGGCGGTATATATTGCACCCCTAAAAGCCCTAGTACGTGA AAGAATGGATGATTGGAAAGTTAGAATAGAAGAAAAACTTGGTAAAAAAGTTATTGAACTAACAGGGGATGTGACTCCTGATATGAAATC CATTGCCAAGGCTGACCTTATCGTCACTACGCCAGAGAAGTGGGATGGAGTCAGCAGAAGCTGGCAAAATAGGAACTATGTTCAGCAAGT CACTATTCTCATCATAGATGAGATCCATCTGCTTGGGGAGGAAAGAGGCCCTGTTCTAGAGGTCATTGTATCTCGAACAAATTTTATCTC ATCACACACAGAAAAGCCTGTTAGAATAGTTGGACTATCTACTGCATTAGCTAATGCCAGAGACCTTGCTGATTGGCTCAATATTAAGCA GATGGGCTTGTTTAACTTCCGACCATCAGTACGCCCAGTTCCACTGGAAGTTCACATTCAAGGCTTTCCAGGTCAACATTACTGTCCTCG TATGGCTAGTATGAACAAGCCTGCATTTCAGGCAATTAGAAGCCATTCTCCAGCCAAACCTGTTTTGATATTTGTCTCATCAAGACGTCA AACTCGTCTTACTGCTTTGGAATTGATCGCCTTCCTGGCTACTGAAGAAGATCCAAAGCAGTGGTTAAACATGGATGAAAGAGAGATGGA GAACATCATTGCAACAGTAAGAGATTCCAACCTCAAGCTGACCCTTGCTTTCGGGATAGGAATGCATCATGCTGGACTACATGAGAGGGA CCGAAAAACAGTAGAGGAACTATTTGTAAACTGTAAAGTTCAGGTTCTTATTGCTACAAGCACATTAGCCTGGGGTGTAAACTTTCCAGC TCATTTAGTAATTATTAAGGGAACAGAATACTATGATGGAAAAACAAGACGTTATGTGGATTTTCCCATTACAGATGTCCTCCAGATGAT GGGGCGTGCTGGGAGGCCGCAGTTCGATGACCAAGGCAAAGCTGTAATTCTAGTTCATGACATAAAGAAAGACTTTTATAAAAAATTTCT TTATGAACCTTTCCCAGTAGAATCAAGTTTATTAGGAGTGCTCTCTGACCACTTAAATGCAGAGATTGCTGGTGGTACAATTACATCTAA GCAAGATGCATTGGATTATATCACCTGGACTTACTTTTTCCGACGTCTTATCATGAATCCCAGCTATTACAATTTGGGTGATGTGAGCCA TGATTCTGTGAACAAGTTTCTGTCCCATCTGATTGAGAAGTCCCTGATTGAATTGGAACTTTCCTACTGTATTGAAATTGGAGAGGATAA TCGCAGCATTGAACCTCTAACTTATGGCCGAATTGCCTCCTATTACTATTTGAAGCATCAAACAGTTAAAATGTTCAAGGACCGCTTGAA GCCTGAATGCAGTACTGAAGAACTGCTTTCAATTCTAAGTGATGCAGAAGAATATACAGATTTGCCAGTGAGACACAATGAAGATCATAT GAATAGTGAACTGGCAAAATGTCTTCCCATTGAATCAAATCCTCATTCATTTGACAGCCCTCACACCAAAGCACATCTCCTGCTACAGGC ACATCTCAGCCGAGCCATGCTACCCTGCCCAGATTATGACACTGATACCAAAACAGTCTTGGACCAAGCTCTCAGAGTATGTCAGGCAAT GCTGGACGTGGCTGCAAACCAGGGCTGGCTGGTGACTGTCCTGAATATCACCAACCTGATTCAGATGGTGATCCAGGGTCGGTGGTTAAA GGACTCTTCTCTTCTTACACTACCAAACATAGAAAACCATCATCTTCACCTTTTCAAGAAATGGAAGCCGATTATGAAGGGCCCACATGC TAGGGGTCGGACCTCCATCGAGTCCCTTCCTGAACTGATCCATGCCTGTGGAGGGAAAGACCATGTATTTAGCTCCATGGTAGAAAGTGA GCTACATGCTGCAAAAACGAAACAGGCATGGAATTTCTTATCTCACTTGCCAGTGATAAATGTTGGCATAAGTGTTAAAGGCTCGTGGGA TGACTTAGTTGAAGGACATAATGAACTCTCTGTCTCAACTCTGACTGCAGACAAACGAGATGACAACAAATGGATCAAATTGCATGCTGA CCAAGAGTATGTGCTTCAAGTGAGCTTGCAGAGAGTCCACTTTGGGTTCCACAAGGGAAAGCCAGAGAGCTGTGCAGTTACTCCTCGATT TCCCAAATCAAAAGACGAAGGATGGTTTTTGATATTAGGAGAAGTGGATAAGAGAGAACTTATTGCTTTGAAAAGAGTAGGATATATTCG AAATCATCATGTTGCTTCCCTTTCTTTTTATACCCCTGAAATACCTGGAAGGTATATCTACACATTATATTTCATGAGTGACTGCTACCT TGGCCTGGACCAGCAGTATGACATCTATCTCAACGTTACACAAGCGAGTCTTTCTGCACAGGTCAACACCAAGGTCTCTGATTCCCTGAC TGACCTGGCATTAAAGTAACTTGACCTGAACAATCCATTTGAAAGGAGTGGCTAAGAATTCTCTCTGTTCAGTCATCTAGACAAATCGAA TTACTTGATGTTTGCCTTGAAAGAATCAACTTCTAACCTCAACCATCCAGGAAATTGACAGTGGCTGCAGTATTGACTCCAGTGACATAA AGTTAACCACAGTGGCCTTTTAACAAATGTTGCCTTTTATAATGTTATCTTTATGAGTTTCTTGATATGTAAGATGAAAAAGCATTTAGA ATAATCTTTTAATTTGTGTATATTTGGGATGATATTTAGGAGCTATCAATCAAATTTTACATCTCACAATGTACTGTTTACATGGATATT GGCTGCTTTTTTTAAGGAAAACCACATTGAGATGTGACAAGTGTTAGGACTTGTCACAGATTTCTAACTCTGCCGCATAAACTATAAATC TGTAAGGTGGTACACAGCGTGTCTTGTTAGCAAAATTTATACTTTGATATGATCACATGTAGAAGTAGCTTCAAGAATTTCTTGTAGTCA TAAATGTTTAATAATATATGATGTAAAATTATATTATGGAGCCTAATGATGATAACAAAGAAAACAATATACTGATCTTAGAAAATGTAG ACATGGTTAACTGGGAAATAAAATATAGAGTGGCACTTCAAGACAAGCTGACTCAATGTTTTCTTCTGCTTCCTTTAAATAATATCCCCT TACTCATCTGTTCTTCTTTTCTTTCCCTTCTACTTCAAGGCTTTATTTCTATTATCTTTCTGACATATTTATTTACAGAAGTAGAGAAGT ATAATCTAATTCATGTTGTAGCACTTACAGATCATATAGTACAATTATTTGTCTTTATGCTCTCCAGGAAAAATCTGAGACAGAAAATTT TTCACCCCTATGGATAGGTTTTCACCTGTAATAAAGAAAATTTCTCTATGTCCAAACAAATTCCTTCTTGAAAAATACTTTTTCAAACTA AAAACTTGTTAAAATTCAATGTTCATATAATATGCATTCTAGTGGAATGAAATTCTACCTTTGTGAAATAATTTCAGTTTTCTTAGCCCT AAAATGAATTATTTTAAAACATTTTCCAATGTCATTGTTACAAATACTAGAATTTAAGTGTTTCTGAAATTGGAATGTATTGCTTGTATA >96320_96320_3_UBE4B-ASCC3_UBE4B_chr1_10093752_ENST00000377153_ASCC3_chr6_101127628_ENST00000369162_length(amino acids)=1493AA_BP=735 MEELSADEVMVFVHARNATVRTAMSLIERAKNCGHIPFFFPTQGHDYVLAEKQVQRSRNKQVRELFPDGFSIHHAGMLRQDRNLVENLFS NGHIKVLVCTATLAWGVNLPAHAVIIKGTQIYAAKRGSFVDLGILDVMQIFGRAGRPQFDKFGEGIIITTHDKLSHYLTLLTQRNPIESQ FLESLADNLNAEIALGTVTNVEEAVKWISYTYLYVRMRANPLAYGISHKAYQIDPTLRKHREQLVIEVGRKLDKAQMIRFEERTGYFSST DLGRTASHYYIKYNTIETFNELFDAHKTEGDIFAIVSKAEEFDQIKVREEEIEELDTLLSNFCELSTPGGVENSYGKINILLQTYISRGE MDSFSLISDSAYVAQNAARIVRALFEIALRKRWPTMTYRLLNLSKVIDKRLWGWASPLRQFSILPPHILTRLEEKKLTVDKLKDMRKDEI GHILHHVNIGLKVKQCVHQIPSVMMEASIQPITRTVLRVTLSIYADFTWNDQVHGTVGEPWWIWVEDPTNDHIYHSEYFLALKKQVISKE AQLLVFTIPIFEPLPSQYYIRAVSDRWLGAEAVCIINFQHLILPERHPPHTELLDLQPLPITALGCKAYEALYNFSHFNPVQTQIFHTLY HTDCNVLLGAPTGSGKTVAAELAIFRVFNKYPTSKAVYIAPLKALVRERMDDWKVRIEEKLGKKVIELTGDVTPDMKSIAKADLIVTTPE KWDGVSRSWQNRNYVQQVTILIIDEIHLLGEERGPVLEVIVSRTNFISSHTEKPVRIVGLSTALANARDLADWLNIKQMGLFNFRPSVRP VPLEVHIQGFPGQHYCPRMASMNKPAFQAIRSHSPAKPVLIFVSSRRQTRLTALELIAFLATEEDPKQWLNMDEREMENIIATVRDSNLK LTLAFGIGMHHAGLHERDRKTVEELFVNCKVQVLIATSTLAWGVNFPAHLVIIKGTEYYDGKTRRYVDFPITDVLQMMGRAGRPQFDDQG KAVILVHDIKKDFYKKFLYEPFPVESSLLGVLSDHLNAEIAGGTITSKQDALDYITWTYFFRRLIMNPSYYNLGDVSHDSVNKFLSHLIE KSLIELELSYCIEIGEDNRSIEPLTYGRIASYYYLKHQTVKMFKDRLKPECSTEELLSILSDAEEYTDLPVRHNEDHMNSELAKCLPIES NPHSFDSPHTKAHLLLQAHLSRAMLPCPDYDTDTKTVLDQALRVCQAMLDVAANQGWLVTVLNITNLIQMVIQGRWLKDSSLLTLPNIEN HHLHLFKKWKPIMKGPHARGRTSIESLPELIHACGGKDHVFSSMVESELHAAKTKQAWNFLSHLPVINVGISVKGSWDDLVEGHNELSVS TLTADKRDDNKWIKLHADQEYVLQVSLQRVHFGFHKGKPESCAVTPRFPKSKDEGWFLILGEVDKRELIALKRVGYIRNHHVASLSFYTP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for UBE4B-ASCC3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for UBE4B-ASCC3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for UBE4B-ASCC3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |